ResearcherCentre National de la Recherche ScientifiqueNo recent work listed
Rémi Samain
Matched on ORCID iD 0000-0003-0568-4993; OpenAlex author ID A5068092442. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 37
2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper
Papers 8
- CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. Co-author DOI 10.1126/sciadv.adi0244↗
- Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenoc… Co-author DOI 10.1002/path.6011↗
- Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages. Co-author DOI 10.1016/j.jcmgh.2021.01.008↗
- Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer Co-author DOI 10.1016/j.pan.2021.05.117↗
- FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer. Co-author DOI 10.15252/emmm.202012010↗
- Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2018-317570↗
- eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. Co-author DOI 10.1172/jci.insight.121951↗
- Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts. Co-author DOI 10.18632/oncotarget.9296↗
Closest collaborators
The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Corinne Bousquet · 7 shared papers, 2016–2022 · strength 0.61
- Paper Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenv… DOI 10.1002/path.6011↗
- Paper Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer DOI 10.1016/j.pan.2021.05.117↗
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Yvan Martineau · 5 shared papers, 2016–2021 · strength 0.41
- Paper Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer DOI 10.1016/j.pan.2021.05.117↗
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Stéphane Pyronnet · 5 shared papers, 2016–2021 · strength 0.41
- Paper Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer DOI 10.1016/j.pan.2021.05.117↗
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Christine Jean · 5 shared papers, 2016–2021 · strength 0.41
- Paper Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer DOI 10.1016/j.pan.2021.05.117↗
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Cindy Neuzillet · 4 shared papers, 2020–2022 · strength 0.41
- Paper Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenv… DOI 10.1002/path.6011↗
- Paper Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer DOI 10.1016/j.pan.2021.05.117↗
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Rémy Nicolle · 3 shared papers, 2021–2022 · strength 0.32
- Paper Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenv… DOI 10.1002/path.6011↗
- Paper Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer DOI 10.1016/j.pan.2021.05.117↗
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Jérôme Raffenne · 3 shared papers, 2021–2022 · strength 0.32
- Paper Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenv… DOI 10.1002/path.6011↗
- Paper Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer DOI 10.1016/j.pan.2021.05.117↗
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Jerome F. Cros · 3 shared papers, 2020–2022 · strength 0.30
- Paper Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenv… DOI 10.1002/path.6011↗
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Hemant Mahendrakumar Kocher · 2 shared papers, 2022–2023 · strength 0.25
- Richard Tomasini · 3 shared papers, 2019–2021 · strength 0.25
- Paper Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With … DOI 10.1016/j.jcmgh.2021.01.008↗
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Paper Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer. DOI 10.1136/gutjnl-2018-317570↗
- Sauyeun Shin · 2 shared papers, 2019–2021 · strength 0.18
- Jérémy Nigri · 2 shared papers, 2019–2021 · strength 0.17
- Emilie Decaup · 2 shared papers, 2016–2020 · strength 0.14
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Paper Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associ… DOI 10.18632/oncotarget.9296↗
- Victoria Sanz‐Moreno · 1 shared paper, 2023 · strength 0.13
- Claire M. Wells · 1 shared paper, 2023 · strength 0.13
- Debashis Sarker · 1 shared paper, 2023 · strength 0.13
- Juliana B. Candido · 1 shared paper, 2023 · strength 0.13
- Annemilaï Tijeras‐Raballand · 1 shared paper, 2022 · strength 0.12
- Vinciane Rebours · 1 shared paper, 2022 · strength 0.12
- Marc Hilmi · 1 shared paper, 2022 · strength 0.12
- Juan Iovanna · 1 shared paper, 2021 · strength 0.11
- Nelson Dusetti · 1 shared paper, 2021 · strength 0.11
- Matteo Ponzo · 1 shared paper, 2021 · strength 0.09
- Ilaria Cascone · 1 shared paper, 2021 · strength 0.09
- Sonia Zaghdoudi · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.